Denis Comte

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


62 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2008 | 2007 | 2005 |
 
Promotion de l’activité physique au quotidien : rôle des professionnels de la santé [Promoting physical activity in everyday life: the role of health care professionals]
Seydoux C., Regina J., de La Harpe R., Dévaud M., Oestreicher S., Grand C., Gremeaux-Bader V., Kraege V., Comte D., 2024/11/20. Revue medicale suisse, 20 (896) pp. 2181-2185. Peer-reviewed.
 
Understanding Myelodysplasia and Inflammation Through the Lense of VEXAS Syndrome: A Review.
Wolff L., Caratsch L., Zhao L.P., Blum S., Comte D., 2024/11/15. Cells, 13 (22). Peer-reviewed.
 
Antibiotiques et réactions cutanées graves chez les seniors : un risque à considérer.
Comte D., 2024/11/06. Revue medicale suisse, 20 (894) p. 2085. Peer-reviewed.
 
Artérite à cellules géantes : échodoppler des artères temporales avant biopsie.
Comte D., 2024/08/21. Revue medicale suisse, 20 (883) p. 1433. Peer-reviewed.
 
Cystatine C : un indicateur clé pour évaluer les risques rénaux et cardiovasculaires.
Comte D., 2024/03/20. Revue medicale suisse, 20 (866) p. 615. Peer-reviewed.
 
Cryoglobulinemic vasculitis triggered by Staphylococcus aureus endocarditis with chronic hepatitis C virus co-infection: a case report and literature review.
Reinberg C., Vingerhoets S., Pavlova O., Guenova E., Papadimitriou-Olivgeris M., Comte D., 2024. Frontiers in immunology, 15 p. 1385086. Peer-reviewed.
Risk factors for allergy documentation in electronic health record: A retrospective study in a tertiary health center in Switzerland.
Ringwald M., Moi L., Wetzel A., Comte D., Muller Y.D., Ribi C., 2024/01. Allergology international, 73 (1) pp. 143-150. Peer-reviewed.
 
Immunosuppresseurs et antécédent de cancer : quel risque de récidive?
Comte D., 2023/11/29. Revue medicale suisse, 19 (852) p. 2271. Peer-reviewed.
Polyarteritis Nodosa: Old Disease, New Etiologies.
Wolff L., Horisberger A., Moi L., Karampetsou M.P., Comte D., 2023/11/23. International journal of molecular sciences, 24 (23). Peer-reviewed.
 
Quand suspecter une immunodéficience chez le patient hospitalisé en médecine interne? [Should we suspect immune deficiency in internal medicine hospitalized patients?]
Gerber C., Bart P.A., Comte D., 2023/11/22. Revue medicale suisse, 19 (851) pp. 2200-2205. Peer-reviewed.
 
Au-delà de l’ombre du VIH : la lymphopénie CD4+ idiopathique.
Comte D., 2023/09/13. Revue medicale suisse, 19 (841) p. 1679. Peer-reviewed.
 
OP0020 The Cellular Metabolism of Sle Nk Cells is Primarily Altered at the Level of Mitochondrial Homeostasis
Fluder N., Humbel M., Ribi C., Comte D., 2023/06., EULAR 2023 European Congress of Rheumatology, 31 May - 3 June pp. 13.1-13 dans Scientific Abstracts.
Granulomatose avec polyangéite : quoi de neuf ? [Granulomatosis with polyangiitis: what's new?]
Ringwald M., Chevalley D., Bongard C., Kissling S., Rotman S., Von Garnier C., Ribi C., Comte D., 2023/04/05. Revue medicale suisse, 19 (821) pp. 674-679. Peer-reviewed.
Maladie des anticorps anti-membrane basale glomérulaire [Anti-glomerular basement membrane disease]
Stevanin M., Kissling S., Daccord C., Rotman S., Comte D., Ribi C., 2023/04/05. Revue medicale suisse, 19 (821) pp. 680-685. Peer-reviewed.
Measurement of circulating CD21-CD27- B lymphocytes in SLE patients is associated with disease activity independently of conventional serological biomarkers.
Horisberger A., Humbel M., Fluder N., Bellanger F., Fenwick C., Ribi C., Comte D., 2022/06/02. Scientific reports, 12 (1) p. 9189. Peer-reviewed.
Management of Beta-Lactam Antibiotics Allergy: A Real-Life Study.
Iuliano S., Senn L., Moi L., Muller Y.D., Ribi C., Buss G., Comte D., 2022. Frontiers in allergy, 3 p. 853587. Peer-reviewed.
SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus Erythematosus.
Humbel M., Bellanger F., Horisberger A., Suffiotti M., Fluder N., Makhmutova M., Mathias A., Du Pasquier R., Fenwick C., Ribi C. et al., 2022. Frontiers in immunology, 13 p. 843059. Peer-reviewed.
Underuse of Epinephrine for the Treatment of Anaphylaxis in the Prehospital Setting.
Dami F., Enggist R., Comte D., Pasquier M., 2022. Emergency medicine international, 2022 p. 5752970. Peer-reviewed.
 
High levels of interleukine-6 in ascites prevent ascites reinfusion during hemodialysis.
Halfon M., Artru F., Fraga M., Comte D., Alberio L., Brunet J.F., Fakhouri F., Kissling S., 2021/09. Clinics and research in hepatology and gastroenterology, 45 (5) p. 101734. Peer-reviewed.
Hépatite autoimmune : mise au point 2021 [Autoimmune hepatitis: 2021 update]
Stamm G.M., Sempoux C., Fraga M., Comte D., Aubert V., Moradpour D., Vionnet J., Moschouri E., 2021/09/01. Revue medicale suisse, 17 (748) pp. 1457-1463. Peer-reviewed.
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients.
Perreau M., Suffiotti M., Marques-Vidal P., Wiedemann A., Levy Y., Laouénan C., Ghosn J., Fenwick C., Comte D., Roger T. et al., 2021/08/09. Nature communications, 12 (1) p. 4888. Peer-reviewed.
Biologiques et lupus érythémateux systémique : nouveautés et perspectives [Biologics and systemic lupus erythematosous : new insights and perspectives]
Clottu A., Horisberger A., Comte D., 2021/04/07. Revue medicale suisse, 17 (733) pp. 684-689. Peer-reviewed.
 
Vaccins contre le Covid-19 : cibles vaccinales, immunogénicité et réactions allergiques [COVID-19 vaccines: vaccine targets, immunogenicity and allergic reactions]
Fallet B., Miauton A., Comte D., Ribi C., Muller Y.D., 2021/04/07. Revue medicale suisse, 17 (733) pp. 690-696.
Allergologie-immunologie - Rhinosinusite chronique avec polypes nasaux : quelle est la place des anticorps monoclonaux en 2020 ? [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?]
Clottu A., Reinhard A., Comte D., 2021/01/13. Revue medicale suisse, 17 (720-1) pp. 13-17. Peer-reviewed.
 
Autoimmune hepatitis as a sequelae of oxcarbazepine-induced drug reaction with eosinophilia and systemic symptoms.
Droz N., Chevrier F., Lapointe A.K., Sempoux C., Fraga M., Comte D., 2021/01. The journal of allergy and clinical immunology. In practice, 9 (1) pp. 580-581. Peer-reviewed.
Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
Zimmerli A., Monti M., Fenwick C., Eckerle I., Beigelman-Aubry C., Pellaton C., Jaton K., Dumas D., Stamm G.M., Infanti L. et al., 2021. Frontiers in immunology, 12 p. 613502. Peer-reviewed.
Innate Lymphoid Cells in Autoimmune Diseases.
Clottu A.S., Humbel M., Fluder N., Karampetsou M.P., Comte D., 2021. Frontiers in immunology, 12 p. 789788. Peer-reviewed.
Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE.
Humbel M., Bellanger F., Fluder N., Horisberger A., Suffiotti M., Fenwick C., Ribi C., Comte D., 2021. Frontiers in immunology, 12 p. 645478. Peer-reviewed.
Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult.
Othenin-Girard A., Regamey J., Lamoth F., Horisberger A., Glampedakis E., Epiney J.B., Kuntzer T., de Leval L., Carballares M., Hurni C.A. et al., 2020/11/02. Swiss medical weekly, 150 pp. w20387. Peer-reviewed.
 
Progressive multifocal leukoencephalopathy responsive to withdrawal of imatinib in a patient with FIP1L1-PDGFRA positive myeloid neoplasm.
Blum S., Dunet V., Comoli P., Tirefort Y., Chalandon Y., Opota O., Comte D., Spertini O., Livio F., Brouland J.P. et al., 2020/09. Leukemia & lymphoma, 61 (9) pp. 2226-2229. Peer-reviewed.
Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes.
Orcurto A., Hottinger A., Wolf B., Navarro Rodrigo B., Ochoa de Olza M., Auger A., Kuntzer T., Comte D., Zimmer V., Gannon P. et al., 2020/08. Journal for immunotherapy of cancer, 8 (2) pp. e001155. Peer-reviewed.
A case report on the cytokine signature profile of immunoglobulin G4-related disease.
Dällenbach J., Moi L., Humair G., Letovanec I., Perreau M., Cherix S., Comte D., Vaucher J., 2020/07. Scandinavian journal of rheumatology, 49 (4) pp. 332-333. Peer-reviewed.
Collapsing glomerulopathy in a COVID-19 patient.
Kissling S., Rotman S., Gerber C., Halfon M., Lamoth F., Comte D., Lhopitallier L., Sadallah S., Fakhouri F., 2020/07. Kidney international, 98 (1) pp. 228-231. Peer-reviewed.
Impact of COVID-19 pandemic on SLE: beyond the risk of infection.
Horisberger A., Moi L., Ribi C., Comte D., 2020/05. Lupus science & medicine, 7 (1). Peer-reviewed.
Maladies autoimmunes dans le contexte de la pandémie COVID-19 [Autoimmune diseases in the context of pandemic COVID-19]
Horisberger A., Moi L., Ribi C., Comte D., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 827-830. Peer-reviewed.
 
Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity.
Katsuyama T., Li H., Comte D., Tsokos G.C., Moulton V.R., 2019/12/02. The Journal of clinical investigation, 129 (12) pp. 5411-5423. Peer-reviewed.
 
Signaling lymphocyte activation molecule family in systemic lupus erythematosus.
Comte D., Karampetsou M.P., Humbel M., Tsokos G.C., 2019/07. Clinical immunology, 204 pp. 57-63. Peer-reviewed.
Effets indésirables des inhibiteurs de points de contrôle immunitaire : diagnostic et prise en charge [Side effects of immune checkpoint inhibitors: diagnosis and management]
Perrinjaquet C., Zaher M., Ferraro D.A., Comte D., Trueb L., Zimmermann S., Coukos G., Orcurto A., 2019/05/15. Revue medicale suisse, 15 (651) pp. 1010-1016. Peer-reviewed.
De la vasculite cutanée isolée aux atteintes systémiques : l’approche diagnostique d’un purpura chez l’adulte [From isolated cutaneous vasculitis to systemic disease : a diagnostic approach to purpura in the adult patient]
Horisberger A., Ghosn J., Di Lucca J., Comte D., 2019/04/03. Revue medicale suisse, 15 (645) pp. 713-718. Peer-reviewed.
 
Manifestations auto-immunes au cours de l’infection chronique par le virus de l’immunodéficience humaine (VIH) [Autoimmune disorders during chronic human immunodeficiency virus (HIV) infection]
Filippidis P., Comte D., 2019/04/03. Revue medicale suisse, 15 (645) pp. 723-731. Peer-reviewed.
A Rare Case of Diffuse Polyarthritis in the Context of an Epididymoorchitis due to Mumps Infection
Van Singer M., Felix N., Perreau M., Lebowitz D., Comte D., 2019. Rheumatology: Current Research, 09 (02). Peer-reviewed.
 
Signaling Lymphocytic Activation Molecule Family Member 1 Engagement Inhibits T Cell-B Cell Interaction and Diminishes Interleukin-6 Production and Plasmablast Differentiation in Systemic Lupus Erythematosus.
Karampetsou M.P., Comte D., Suárez-Fueyo A., Katsuyama E., Yoshida N., Kono M., Kyttaris V.C., Tsokos G.C., 2019/01. Arthritis & rheumatology, 71 (1) pp. 99-108. Peer-reviewed.
Immunothérapie sublinguale pour le traitement de la rhinoconjonctivite et l’asthme allergique : guide pratique [Sublingual immunotherapy for the treatment of allergic rhinoconjonctivitis and asthma : a practical approach]
Ghosn J., Spertini F., Comte D., 2018/04/04. Revue medicale suisse, 14 (601) pp. 735-739. Peer-reviewed.
 
Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus.
Comte D., Karampetsou M.P., Yoshida N., Kis-Toth K., Kyttaris V.C., Tsokos G.C., 2017/05. Arthritis & rheumatology (Hoboken, N.J.), 69 (5) pp. 1035-1044. Peer-reviewed.
 
Brief Report: CD4+ T Cells From Patients With Systemic Lupus Erythematosus Respond Poorly to Exogenous Interleukin-2.
Comte D., Karampetsou M.P., Kis-Toth K., Yoshida N., Bradley S.J., Kyttaris V.C., Tsokos G.C., 2017/04. Arthritis & rheumatology, 69 (4) pp. 808-813. Peer-reviewed.
Expression patterns of signaling lymphocytic activation molecule family members in peripheral blood mononuclear cell subsets in patients with systemic lupus erythematosus.
Karampetsou M.P., Comte D., Kis-Toth K., Kyttaris V.C., Tsokos G.C., 2017. PloS one, 12 (10) pp. e0186073. Peer-reviewed.
 
SLE-Associated Defects Promote Altered T Cell Function.
Crispin J.C., Hedrich C.M., Suárez-Fueyo A., Comte D., Tsokos G.C., 2017. Critical reviews in immunology, 37 (1) pp. 39-58. Peer-reviewed.
 
Engagement of SLAMF3 enhances CD4+ T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosus.
Comte D., Karampetsou M.P., Kis-Toth K., Yoshida N., Bradley S.J., Mizui M., Kono M., Solomon J.R., Kyttaris V.C., Tsokos G.C., 2016/08/16. Proceedings of the National Academy of Sciences of the United States of America, 113 (33) pp. 9321-9326. Peer-reviewed.
 
Decreased SAP Expression in T Cells from Patients with Systemic Lupus Erythematosus Contributes to Early Signaling Abnormalities and Reduced IL-2 Production.
Karampetsou M.P., Comte D., Kis-Toth K., Terhorst C., Kyttaris V.C., Tsokos G.C., 2016/06/15. Journal of immunology, 196 (12) pp. 4915-4924. Peer-reviewed.
ICER is requisite for Th17 differentiation.
Yoshida N., Comte D., Mizui M., Otomo K., Rosetti F., Mayadas T.N., Crispín J.C., Bradley S.J., Koga T., Kono M. et al., 2016. Nature Communications, 7 p. 12993. Peer-reviewed.
 
Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4-Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus.
Kis-Toth K., Comte D., Karampetsou M.P., Kyttaris V.C., Kannan L., Terhorst C., Tsokos G.C., 2016/01. Arthritis & rheumatology, 68 (1) pp. 164-173. Peer-reviewed.
 
T cells as a therapeutic target in SLE.
Comte D., Karampetsou M.P., Tsokos G.C., 2015. Lupus, 24 (4-5) pp. 351-363. Peer-reviewed.
 
Adverse reactions to biologic agents and their medical management.
Boyman O., Comte D., Spertini F., 2014. Nature Reviews. Rheumatology, 10 (10) pp. 612-627. Peer-reviewed.
CD160-Associated CD8 T-Cell Functional Impairment Is Independent of PD-1 Expression.
Viganò S., Banga R., Bellanger F., Pellaton C., Farina A., Comte D., Harari A., Perreau M., 2014. Plos Pathogens, 10 (9) pp. e1004380. Peer-reviewed.
Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders.
Perreau M., Vigano S., Bellanger F., Pellaton C., Buss G., Comte D., Roger T., Lacabaratz C., Bart P.A., Levy Y. et al., 2014. Journal of Experimental Medicine, 211 (10) pp. 2033-2045. Peer-reviewed.
 
Allergies aux produits de contraste radiologiques [Allergy to radiographic contrast media].
Vionnet J., Petitpierre S., Fumeaux A., Meuli R., Spertini F., Comte D., 2013. Revue Médicale Suisse, 9 (382) pp. 812-818.
Allergie aux β-lactamines [Allergy to beta-lactam antibiotics]
Comte D., Petitpierre S., Spertini F., Bart P.A., 2012/04/18. Revue medicale suisse, 8 (337) pp. 836,838-842. Peer-reviewed.
Immunodéficience commune variable: ce qu'il faut savoir [Common variable immune deficiency: what you need to know].
Buss G., Comte D., Spertini F., Bart P.A., Petitpierre S., 2012. Revue Médicale Suisse, 8 (337) pp. 859-864. Peer-reviewed.
Allergie aux venins d'hyménopteres: nouveautés diagnostiques et prise en charge [Hymenoptera venom allergy: new diagnostic tools and management]
Comte D., Petitpierre S., Bart P.A., Spertini F., Leimgruber A., 2011/04/20. Revue medicale suisse, 7 (291) pp. 844-849. Peer-reviewed.
 
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.
Ciuffreda D., Comte D., Cavassini M., Giostra E., Bühler L., Perruchoud M., Heim M.H., Battegay M., Genné D., Mulhaupt B. et al., 2008. European Journal of Immunology, 38 (10) pp. 2665-2677.
 
Une cause rare d'adénopathie cervicale [A rare cause of cervical adenopathy]
Comte D., Lamy O., Schwab M., 2007. Schweizerische Rundschau fur Medizin Praxis, 96 (46) pp. 1821-1824.
 
Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection
Dutoit V., Ciuffreda D., Comte D., Gonvers J. J., Pantaleo G., 2005/12. European Journal of Immunology, 35 (12) pp. 3493-504.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University